NFlection Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.nflectionrx.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
Phase 2
Completed
- Conditions
- Neurofibromatosis 1Cutaneous Neurofibroma
- Interventions
- Drug: NFX-179 gelDrug: Vehicle gel
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- NFlection Therapeutics, Inc.
- Target Recruit Count
- 199
- Registration Number
- NCT05005845
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Northwest Arkansas Clinical Trials Center, PLLC, Rogers, Arkansas, United States
🇺🇸Center for Dermatology Clinical Research, Inc., Fremont, California, United States
NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
Phase 2
Completed
- Conditions
- Neurofibromatosis 1Cutaneous Neurofibroma
- Interventions
- Drug: NFX-179 GelDrug: Vehicle Gel
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- NFlection Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04435665
- Locations
- 🇺🇸
Center for Dermatology Clinical Research, Inc., Fremont, California, United States
🇺🇸Minnesota Clinical Study Center, New Brighton, Minnesota, United States
🇺🇸Skin Search of Rochester, Inc., Rochester, New York, United States
News
No news found